Article Correctness Is Author's Responsibility: Partners receive $4.25 million to develop universal surveillance platform for disease outbreaks

(US Army Medical Research Institute of Infectious Diseases) During this multi-year program, Ceres Nanosciences and Tasso, Inc. will partner on a device for simple, painless collection of large-volume capillary blood samples in remote environments, working with infectious disease experts and advanced biodefense laboratories at George Mason University and United States Army Medical Research Institute of Infectious Diseases. Their goal is to develop an effective disease surveillance platform that can be rapidly deployed in the field, operated by untrained users, and improve early response.
Posted in Uncategorized